Evaluation of Soluble Mesothelin-related Peptide as a Diagnostic Marker of Malignant Pleural Mesothelioma Effusions: Its Contribution to Cytology

被引：21

作者：

Canessa, Pier Aldo ^{[1
]}

Franceschini, Maria Cristiana ^{[2
]}

Ferro, Paola ^{[2
]}

Battolla, Enrico ^{[3
]}

Dessanti, Paolo ^{[2
]}

Manta, Carmen ^{[1
]}

Sivori, Massimiliano ^{[1
]}

Pezzi, Riccardo ^{[4
]}

Fontana, Vincenzo ^{[4
]}

Fedeli, Franco ^{[2
]}

Pistillo, Maria Pia ^{[5
]}

Roncella, Silvio ^{[2
]}

机构：

[1] Div Pneumol, La Spezia, Italy

[2] Div Histopathol & Cytopathol, La Spezia, Italy

[3] Div Clin Pathol ASL5, La Spezia, Italy

[4] IRCCS AOU San Martino IST, Epidemiol Biostat & Clin Trials Unit, Genoa, Italy

[5] IRCCS AOU San Martino IST, Tumor Genet & Epigenet Unit, Genoa, Italy

来源：

CANCER INVESTIGATION | 2013年 / 31卷 / 01期

关键词：

Cytology; ELISA; Mesothelin; Mesothelioma; Pleural effusion; Tumor; CLINICAL-SIGNIFICANCE; LUNG-CANCER; BIOMARKERS; EXPERIENCE; MANAGEMENT; PROTEINS; FLUID; SERUM;

D O I：

10.3109/07357907.2012.749265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Soluble mesothelin-related peptide (SMRP) is regarded as an FDA approved biomarker for the diagnosis and monitoring of pleural malignant mesothelioma (MPM). We detected the SMRP levels in pleural effusions (PE) by means of an ELISA and analyzed their diagnostic relevance to differentiate MPM from benign pathology and from non-MPM pleural metastasis. Comparison with cytology in MPM-PE was also performed. We found that SMRP detection in MPM-PE can help the diagnosis of MPM and provide additional diagnostic value to cytology. We concluded that SMRP test may be incorporated into clinical practice of PE from patients suspicious for MPM.

引用

页码：48 / 55

页数：8

共 50 条

[41] Soluble mesothelin related peptides: A potential biomarker for malignant pleural mesothelioma.
Pass, HI
Wolaniuk, D
Wali, A
Thiel, R
Hellstrom, I
Hellstrom, K
Sardesai, NY
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 844S - 844S
[42] Detection of malignant mesothelioma in asbestos-exposed individuals: The potential role of soluble mesothelin-related protein
Creaney, J
Robinson, BWS
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (06) : 1025 - +
[43] Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma
Battolla, Enrico
Canessa, Pier Aldo
Ferro, Paola
Franceschini, Cristiana
Fontana, Vincenzo
Dessanti, Paolo
Pinelli, Valentina
Morabito, Anna
Fedeli, Franco
Pistillo, Maria Pia
Roncella, Silvio
ANTICANCER RESEARCH, 2017, 37 (03) : 1387 - 1391
[44] Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: Evaluation in comparison with mesothelin
Iwahori, Kota
Osaki, Tadashi
Serada, Satoshi
Fujimoto, Minoru
Suzuki, Hidekazu
Kishi, Yoshiro
Yokoyama, Akihito
Hamada, Hironobu
Fujii, Yoshihiro
Yamaguchi, Kentaro
Hirashima, Tomonori
Matsui, Kaoru
Tachibana, Isao
Nakamura, Yusuke
Kawase, Ichiro
Naka, Tetsuji
LUNG CANCER, 2008, 62 (01) : 45 - 54
[45] EVALUATION OF UTILITY OF SOLUBLE MESOTHELIN-RELATED PEPTIDE AND FOLATE RECEPTOR ALPHA IN DIAGNOSIS OF OVARIAN CANCER
Janas, L.
Glowacka, E.
Zimna, K.
Szyllo, K.
Nowak, M.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1955 - 1955
[46] Serum soluble mesothelin related proteins level is predictive of survival among pleural malignant mesothelioma patients
Puntoni, R.
Mutti, L.
Foddis, R.
Cristaudo, A.
Neri, M.
Paganuzzi, M.
Filiberti, R.
ANNALS OF ONCOLOGY, 2007, 18 : 48 - 49
[47] Secretary leukocyte peptide inhibitor (SLPI) in pleural fluid is useful as a diagnostic marker of malignant pleural mesothelioma
Fujimoto, Nobukazu
Kojima, Yoko
Kishimoto, Takumi
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[48] Serum Levels of Soluble Mesothelin-Related Peptides in Malignant and Nonmalignant Asbestos-Related Pleural Disease: Relation with Past Asbestos Exposure
Portal, Jose A. Rodriguez
Becerra, Eulogio Rodriguez
Rodriguez, David Rodriguez
Michavila, Inmaculada Alfageme
Martinez, Aida Quero
Roza, Carmen Diego
Jimenez, Antonio Leon
Montes, Isabel Isidro
Rivas, Pilar Cebollero
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (02) : 646 - 650
[49] Serum Levels of Soluble Mesothelin-Related Peptides in Malignant and Non-Malignant Asbestos-Related Pleural Disease: Relation with past Asbestos Exposure.
Rojano-Broz, B.
Rodriguez-Portal, J. A.
Rodriguez-Becerra, E.
Rodriguez, D.
Alfageme, I.
Quero Martinez, A.
Diego, C.
Leon-Jimenez, A.
Isidro Montes, I.
Cebollero, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[50] Serum soluble mesothelin-related protein (SMRP) and fibulin-3 levels correlate with baseline malignant pleural mesothelioma (MPM) tumor volumes but are not useful as biomarkers of response in an immunotherapy trial
Katz, Sharyn, I
Roshkovan, Leonid
Berger, Ian
Friedberg, Joseph S.
Alley, Evan W.
Simone, Charles B., II
Haas, Andrew R.
Cengel, Keith A.
Sterman, Daniel H.
Albelda, Steven M.
LUNG CANCER, 2021, 154 : 5 - 12

← 1 2 3 4 5 →